Investors/ Analysts Meeting

August 05, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub.: Intimation of Investors/ Analysts Meeting Dear Sirs, Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be physically meeting the following institutional investors on August 13, 2026 to August 14, 2026, in one-on-one / group meetings in Mumbai. These meetings are organized by Emkay Global Financial Services as a part of their Flagship Conference (Emkay Confluence). The schedule may undergo change due to exigencies on the part of Investors / Analysts / Company. 1. HDFC AMC 2. ICICI Prudential AMC 3. Karma Capital 4. Motilal Oswal AMC 5. ICICI Prudential Life Insurance 6. ITI Mutual Fund 7. Tata Asset Management 8. MK Ventures In the meetings, we shall discuss the Q1’FY27 Earnings presentation that shall be filed on 10th Aug, 2026 post-disclosing Q1’FY27 financial results. This is for your information and record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary